Pedro Dorado

Pedro Dorado

Universidad de Extremadura - Badajoz / Spain
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4338077
University of Extremadura
person_outline Pedro Dorado's MOST POPULAR ARTICLES
1-) Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the CYP2C9 genotypeÜ Yasar, C Forslund‐Bergengren, G Tybring, P Dorado, A LLerena, ...Clinical Pharmacology & Therapeutics 71 (1), 89-98, 20022672002
2-) CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteersP Dorado, R Berecz, MJ Norberto, Ü Yasar, ML Dahl, A LLerenaEuropean journal of clinical pharmacology 59 (3), 221-225, 20031252003
3-) QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrationsA Llerena, R Berecz, P Dorado, A de la RubiaJournal of psychopharmacology 18 (2), 189-193, 20041012004
4-) Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditionsA LLerena, P Dorado, R Berecz, AP González, EM Peñas-LLedóEuropean journal of clinical pharmacology 59, 869-873, 20041022004
5-) Development of a PCR-Based Strategy for CYP2D6 Genotyping Including Gene Multiplication of Worldwide Potential UseP Dorado, MC Cáceres, E Pozo-Guisado, ML Wong, J Licinio, A LLerenaBiotechniques 39 (sup4), 571-574, 2005982005